10x Genomics, Inc. - 10-Q Filing
10x Genomics reports Q3 2026 financial results including revenue from product, service, and licensing segments.
Tickers: $TXG
Read the full article at SEC EDGAR
Part of the story Cogent Communications Reports Q3 2026 Results with Improved EBITDA Margins and Wavelength Growth (22 articles)